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Bombina variegata/B. orientalisbina species contain peptides and small proteins with interesting biological
properties. These include bombesin, thyrotropin releasing hormone, BSTI and Bv8. In this review, the
biosynthesis and antimicrobial activity of two groups of peptides, bombinins and bombinins H, are described.
To date, these have only been found in Bombina skin. They are derived from common precursors containing
one or two bombinin copies at the amino and a single bombinin H at the carboxyl end. Bombinins are active
against Gram-positive and Gram-negative bacteria and fungi but virtually inactive in haemolysis assays.
Conversely, bombinins H have lower bactericidal activities but lyse erythrocytes. In the skin secretions,
bombinins H are present in two sizes with either 20 or 17 amino acids. Moreover, they occur as epimers with
either an L- or a D-amino acid at position 2. An enzyme catalyzing this inversion of chirality of an amino acid
in peptide linkage has been isolated from Bombina skin secretions. In different tests, also with different
stages of the life cycle of Leishmania parasites, the D-forms were found to be more active. Biophysical studies
have yielded some insight into the different behaviours of the epimers in model membranes.
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In skin secretion of amphibians, a multitude of antimicrobial
peptides have been discovered [1,2]. Many of these are linear peptides
that can form amphipathic helices, others have a single disulﬁde
bridge, and a few, as discussed in some detail in this review, also
contain a D-amino acid. These amphibian peptides have widely
differing activities against Gram-positive or Gram-negative bacteria,
fungi and a parasite. The main function of these constituents of skin
secretions is the inhibition of microbial growth on the surface of frogs,
many of which live in humid environments. In addition, skin
secretions also contain many different peptides related to mammalian
hormones and neurotransmitters [3,4]. The complete “cocktail”iochimiche “A. Rossi Fanelli”,
e, Italy. Tel.: +39 06 4456663;
ra).
ll rights reserved.produced in the skin of frogs apparently also serves as a deterrent
against predators.
Here we present an overview on the structure and function of
antimicrobial peptides from skin secretions of Bombina species. These
are members of an ancient group of frogs which, at least according to
some herpetologists, belongs to a separate family, the Bombinatoridae
of the suborder Archaeobatrachia. Besides the three main species,
Bombina bombina, Bombina variegata and Bombina orientalis, a few
others, most notably Bombina maxima from some regions in China,
have been identiﬁed. The antimicrobial peptides produced in the skin
of these frogs, the bombinins and bombinins H, have not been
detected in other amphibian genera.
Secretory glands in the skin of these frogs also produce several
other peptides with interesting biological activities. Two of thesewere
already discovered more than 30 years ago. One was TRH (thyro-
tropin-releasing hormone), a peptide ﬁrst isolated from mammalian
hypothalamus. Bombina skin contains as much as 40 μg/g fresh tissue
of this tripeptide [5], orders of magnitude more than present in the
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is bombesin [6]. This and related peptides from other frogs are the
amphibian homologues of the mammalian gastrin-releasing peptide.
Bombesin is a growth factor for small cell lung cancer and other tumor
cells. Numerous studies have been published describing the various
pharmacological activities of bombesin and its homologues [for a
recent review, see [7]]. PubMed lists more than 4000 publications
where the term “bombesin” is mentioned in the title and/or the
abstract.
More recently, two other constituents of Bombina skin secretions
have been discovered. One is the trypsin inhibitor BSTI (Bombina
skin trypsin/thrombin inhibitor) which surprisingly is related to
protease inhibitors from nematodes [8]. In addition, a small protein
termed Bv8 (B. variegata, molecular mass 8 kDa) was found [9]. This
had originally only a relative in the venom of the black mamba [10],
but in recent years, two mammalian homologues have been
characterized. These are EG-VEGF/prokineticin 1 and mammalian
Bv8/prokineticin 2 [11–13]. They all belong to a small group of
proteins containing around 80 amino acids including 10 cysteines,
for which, derived from the conserved amino-terminal sequence,
the name AVIT family has been proposed [14]. In mammals,
members of this family bind to two G-protein-coupled receptors
[15,16] and thereby elicit an astounding variety of biological effects
[see ref. [17] for a recent review]. For example, they induce
hyperalgesia [8,18], stimulate endothelial cell vascular growth [19],
and play a role in circadian rhythm [20]. Moreover, mammalian Bv8
produced by myeloid cells was shown to promote tumor growth
[21], a ﬁnding with promising therapeutic implications. Mutations
in human prokineticin 2/Bv8 and/or its receptor are one of the
causes for the Kallmann syndrome, a genetic disease characterized
by an impaired development of the olfactory bulb and severe
defects in the gonads [22]. This is another example how research on
the constituents of skin secretions from amphibians can lead to
important discoveries relevant for mammalian physiology.
2. Bombinins: structure and biosynthesis
Studies on the skin secretions of the two European species B.
bombina and B. variegata were already started in the early sixties in
the group of H. Michl in Vienna [23]. At that time, the pentapeptide
Glu-His-Phe-Ala-Asn-amide could be characterized from this source.
About 10 years later it was shown that this was the carboxy-terminal
part of a larger peptide termed bombinin which was reported to have
antibacterial and haemolytic activities [24].
After a hiatus of about 20 years, the constituents of skin secretions
of Bombina species were studied again by groups in Rome, Salzburg
and San Francisco using modern separation and amino acid sequen-
cing techniques as well as cDNA cloning. In case of B. variegata it could
be shown that a family of peptides related to the original bombininFig. 1. Some representative amino acid sequences of bombinins, bombinins H and maximexisted. They all contain 27 residues which differ at some positions in
the amino-terminal half, while the rest is identical [25]. Similar results
were obtained with bombinins from another species, B. orientalis [26].
Amino acid sequences of bombinins, obtained either by direct peptide
sequencing or by cDNA cloning, are reported in Fig. 1.
From the sequence of the bombinin precursors obtained via cDNA
cloning one could predict the existence of another peptide [25,26].
Indeed, several variants of this peptide could be detected in skin
secretions of B. variegata and B. orientalis. These were named
bombinins H to indicate that, as opposed to bombinins, these are
more hydrophobic and have haemolytic activity [27]. Some bombinins
H isolated from B. orientalis contained 17 instead of 20 amino acid
residues [28]. More recently, homologues of both groups of peptides
were also characterized from skin of B. maxima; these were named
maximins and maximins H, respectively [29].
Interestingly, in some of these bombinins H the second amino acid
was found to be D-alloisoleucine [27]. As reviewed elsewhere,
peptides containing a D-amino acid have been found in skin of other
frogs [30], in the venom of the male platypus [31], and in a variety of
invertebrate species [reviewed in [28,30,32]].
The function of D-amino acids in secreted peptides varies. In case of
the bombinins, the antimicrobial activity of the all-L-versus the D-2-
variant is relatively small (see below). Conversely, in case of the
dermorphins and deltorphins only those with a D-amino acid at
position two bind to opiate receptors. If the amino-terminal sequence
has a beta-strand structure, the side chain of the D-residue would be
“sandwiched” between the ones of the L-amino acids in position one
and three, thereby yielding a new structural element.
An enzyme converting L-isoleucine to D-alloisoleucine at position 2
of the mature peptide has been characterized from Bombina skin
secretions [33]. This inversion of chirality of an amino acid in peptide
linkage occurs via de-protonation/protonation at the α-carbon,
apparently in the absence of any cofactor. Such a reaction mechanism
has also been demonstrated for an isomerase from the venom of a
spider [34]which converts an L-Ser close to the carboxyl end of a 48-
residue toxin to the D-isomer. However, the frog and the spider
enzyme have different amino acid sequences.
Interestingly, DNA sequences potentially coding for proteins
related to the Bombina isomerase are present in the genome of
different vertebrates. The closest homologue was found in an EST
library from the frog Xenopus tropicalis (65% sequence identity in a
fragment of close to 300 amino acids). More distant relatives have
been found in the genomes of e.g. ﬁsh, chicken and man [33]. It is,
however, currently not known whether any of these genes codes for
an active isomerase.
More recently, isomerase activity has been detected in the venom
of themale platypus. This venom contains two peptides, one related to
beta-defensins and the other to C-type natriuretic peptides [31],
which both contain a D-amino acid at position 2. Using a partiallyins H. D-amino acids in position 2 are italicized. Identical residues are marked (⁎).
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isomerase has been determined [35].
Genes encoding the precursors of bombinins were cloned from B.
orientalis [36,37] (see Fig. 2). These are comprised of two exons
separated by large introns (1–2 kb). Exon 1 codes for the signal
peptide; exon 2 includes the remaining coding region comprising the
sequences of the mature peptides as well as acidic and spacer
peptides. The genetic information differs in the two genes: the ﬁrst
gene (BLP-3) codes for two copies of a bombinin-like peptide (BLP-3)
and one copy of a bombinin H-related peptide, whereas the second
gene (BLP-7) codes for a single copy of each peptide. The same
organization was present in the various cDNA clones isolated from B.
variegata [1,25]. The nucleotide sequences of exon 1 and the acidic and
spacer peptides in the two genes are very similar. Canonical Lys-Arg
sequences are ﬂanking the putative peptides for the correct proces-
sing, plus a Gly residue necessary for the C-terminal amidation. In the
promoter regions of these genes, binding sites for NF-κB and NF-IL6
are present (Fig. 2). A common regulation of the expression ofFig. 2. Schematic representation of the BLP-3 and BLP-7 genes from B. orientaliswith the indi
pro-parts, spacer peptides, one or two copies of a bombinin-like peptide (BLP) and one copy oantimicrobial peptide genes occurs in amphibians involving the
cooperation of a multitude of transcription factors, including those
acting in the activation of the mammalian acute-phase response.
3. Biological activity of bombinins
The antimicrobial activity of either bombinin-like peptides or
bombinins H can be distinguished on the basis of their cytolytic
properties. Bombinins were found to be active against Gram-positive
(Bacillus megaterium Bm11, Staphylococcus aureus Cowan1) and
Gram-negative (Escherichia coli D21, E. coli D22, Yersinia pseudotu-
berculosis, Pseudomonas aeruginosa ATCC 15692) bacteria as well as
against Candida albicans; however, they have no appreciable haemo-
lytic capacity (Table 1) [38]. Conversely, bombinins H generally have a
lower antibacterial but a higher haemolytic activity [1,25,27].
Subsequently, the interest of researchers has focused on the
functional signiﬁcance of the D-amino acid present in the sequences
of some bombinins H containing either 20 or 17-residues. Thesecation of promoter sites. Exon 1 contains the predicted signal sequence. Exon 2 contains
f a bombinin H peptide (GH, gene-derived bombinin H) [modiﬁed from ref. [32 and 33]].
Table 1
Antibacterial and haemolytic activities of bombinins
Peptide BLP-1 BLP-3 H2 H4 H6 H7
Lethal concentration (μM)
Gram-negative bacteria
Escherichia coli D21 1.7 3.0 21.4 4.7 NA NA
Escherichia coli D22 1.5 0.9 4.4 3.1 NA NA
Yersinia pseudotuberculosis YPIII 0.8 0.5 7.3 2.0 NA NA
Pseudomonas aeruginosa ATCC 15692 6.3 9.2 NA NA NA NA
Pseudomonas syringae pv tabaci ND ND 32.0 8.2 NA NA
Aeromonas hydrophila Bo-3N ND 25.7 NA NA NA NA
Enterobacter agglomerans Bo-1S ND 1.9 30.0 11.3 NA NA
Gram-positive bacteria
Bacillus megaterium Bm11 0.3 0.8 1.4 0.8 NA 25
Staphylococcus aureus Cowan I 3.4 1.7 4.7 3.0 NA NA
Staphylococcus lentus ND ND 2.0 0.6 NA NA
Micrococcus luteus ND ND 2.0 0.2 NA NA
Yeasts
Candida albicans ATCC 10231 0.4 0.4 3.1 1.6 NA NA
Candida guiller-mondii ND ND 1.3 0.7 NA NA
Candida tropicalis ND ND 1.1 0.6 NA NA
% haemolysis at 15 μM b10 b10 11.0 28.0 78.0 20.0
Lethal concentration values were measured with the inhibition zone assay.
NA, not active; ND, not determined.
Data taken from refs. [35,36].
Fig. 3. Transmission Electron Microscopy images of Leishmania donovani promastigotes.
a, control; b, parasites after treatment with bombinin H2 (9 µM). Parasites were ﬁxed
for 1 h with 5% (w/v) glutaraldehyde in phosphate buffered saline, containing 2.5% (w/
v) osmium tetraoxide, gradually dehydrated in ethanol and propylene oxide. Membrane
disruption, as well as depletion of electron-dense cytoplasmic material can be observed
in peptide-treated promastigotes (Bar=0.5 μm). (Photo by J.M. Saugar).
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to a deeper knowledge of their biological properties [38,39]. In
particular, the pairs bombinin H2/H4 and H6/H7 were analysed. Of
these, the cationic H2/H4 peptides containing 20 amino acids were
more active against Gram-positive bacteria. Between the two, peptide
H4 containing the D-amino acid had a stronger antibiotic activity and a
higher rate of killing against the microorganisms tested. The only
exception was Aeromonas hydrophila Bo-3N, a bacterial species
belonging to the natural ﬂora on the skin of B. orientalis [40], where
the all-L H2-peptide was more active. Both H2 and H4 were also found
to be active against spores of the fungus Phytophthora nicotianae, with
a minimal fungistatic concentration of 10 and 18 μM, respectively [41].
The more hydrophobic bombinins H6 and H7, when assayed in
agarmedium, were devoid of any antibacterial activity, possibly due to
their poor solubility and reduced diffusion rate. In solution, only the D-
amino acid-containing H7 had a bactericidal effect against some
bacterial strains. In particular, H7 was found to be speciﬁcally active
against A. hydrophila, thus representing a possible modulator of the
natural ﬂora. Additional experiments indicated that the increase in
hydrophobicity does not increase the antimicrobial activity and that
the single positive charge of H7 is not essential [38,42].
The membrane permeabilization experiments indicated that
bombinins H2 and H4 cause large damage at the cell membranes
which leads to protein leakage. Apparently, H7 damages the
membrane to a lesser extent so that it becomes leaky only to small
molecules. The biological activity of H6 is mainly directed against
eukaryotic cells, such as erythrocytes, containing membranes com-
posed of zwitterionic phospholipids. Indeed, H6 caused 60% haemo-
lysis at a very low peptide concentration (4 μM) [38].
Bombinins H2/H4 were also assayed on Leishmania, a protozoan
pathogen endemic in many parts of the world. The peptide H4 was
found to be lethal to promastigotes and amastigotes of Leishmania
parasites with LC50 values signiﬁcantly lower than H2 [43].
However, the ﬁnal effect on the parasite morphology was similar
for both epimers and characterized by a marked damage at the
membrane (Fig. 3).
To study the biophysical basis for the different behaviours of the
two epimers, the structure of the peptides was analysed with ATR-
FTIR and CD spectroscopy in membranes mimicking those of
mammals, bacteria and Leishmania promastigotes, respectively [43].
These studies revealed that: (i) a D-amino acid in the second positiondoes not destabilize the α-helical content of the peptide and (ii) only
H2 forms β-sheet aggregates in the model promastigote's membrane.
In addition, using surface plasmon resonance measurements, the
binding afﬁnity of these peptides to the Leishmaniamodel membrane
was determined. Probably due to its reduced hydrophobicity,
bombinin H2 was found to have a lower binding afﬁnity than H4
[43]. Further studies using high-resolution 1H NMR spectroscopy and
a paramagnetic probe indicated that in a membrane mimetic
environment the randomly ordered N-terminal segment was exposed
to solvent [44].
Folding propensities of H2 and H4were also investigated bymeans
of circular dichroism measurements and molecular dynamics simula-
tions [45]. It could be shown that in solution H2 has a markedly higher
tendency to fold, whereas the stereochemical isomerization of
isoleucine to D-alloisoleucine in position 2 drastically decreases the
ability of bombinin H4 to form intrapeptide contacts [45].
The insertion of a D-amino acid in the peptide sequence makes it
more resistant to enzymatic degradation and slows down serum
clearance. However, the reason for the different activities of the two
isomers against Leishmania seems to be more complex. The isomer-
ization of an L- to a D-amino acid can lead to new structural elements
which can not be formed by all-L sequences, like e.g. the side-chain of
the D-residue being “sandwiched” between the side chains of the two
adjacent L-amino acids [46]. This can modulate not only stability and
bioavailability but also, as in case of the bombinins, the biophysical
properties by preventing the formation of oligomers thereby increas-
ing its antimicrobial activity.
The structural and the related functional differences of these
peptides suggest that they act throughmore than onemechanism, and
this may represent a possible way to prevent the development of
bacterial resistance. For these reasons, several amphibian peptides
and their analogues have been assayed against multidrug-resistant
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therapeutic use.
Moreover, as recently demonstrated for the amphibian peptides
temporins [48], but not yet addressed in the studies carried out on
bombinins, synergistic effects in the activity of the different
combinations of bombinin and bombinin H peptides may in fact
determine the overall antimicrobial potency of the skin secretion of
these frogs.
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